E. A. Eisenhauer
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 8
-
- Endometrial and Cervical Cancer Treatments 5
- Co-authors
- J. B. VermorkenM. van GlabbekeElisabeth G.E. de VriesGeke A.P. HospersD.S. ChiRobert G. BristowKarl C. PodratzGiacomo Aletti
- Journals
- Annals of Oncology (11 papers)Journal of Clinical Oncology (7 papers)British Journal of Cancer (2 papers)International Journal of Gynecological Cancer (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
E. A. Eisenhauer
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Reproductive Medicine 504
- Obstetrics and Gynecology 241
- Oncology 404
- Cancer Research 149
- Pathology and Forensic Medicine 142
Countries citing papers authored by E. A. Eisenhauer
This map shows the geographic impact of E. A. Eisenhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. A. Eisenhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. A. Eisenhauer more than expected).
Fields of papers citing papers by E. A. Eisenhauer
This network shows the impact of papers produced by E. A. Eisenhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. A. Eisenhauer. The network helps show where E. A. Eisenhauer may publish in the future.
Co-authors
The 25 scholars most cited alongside E. A. Eisenhauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 229 | |
| 2 | 2011 | 38 | |
| 3 | 2011 | 35 | |
| 4 | 2010 | 1 | |
| 5 | 2010 | 1 | |
| 6 | 2007 | 161 | |
| 7 | 2007 | 24 | |
| 8 | 2005 | 20 | |
| 9 | 2004 | 6 | |
| 10 | First line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel-epirubicin-carboplatin (TEC) vs paclitaxel-carboplatin (TC). Interim results of an NSGO-EORTC GCG - NCIC CTG intergroup Phase III study | 2002 | 4 |
| 11 | 1999 | 2 | |
| 12 | 1999 | 2 | |
| 13 | 1999 | 87 | |
| 14 | 1999 | 95 | |
| 15 | 1997 | 230 | |
| 16 | 1995 | 28 | |
| 17 | 1993 | 3 | |
| 18 | 1988 | 18 | |
| 19 | 1988 | 32 | |
| 20 | Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study. | 1986 | 27 |
About E. A. Eisenhauer
E. A. Eisenhauer is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), Cancer Treatment and Pharmacology (6 papers), Endometrial and Cervical Cancer Treatments (5 papers), Lung Cancer Treatments and Mutations (5 papers), PARP inhibition in cancer therapy (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Research Studies (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Reproductive Medicine (504 citations), Obstetrics and Gynecology (241 citations), Oncology (404 citations), Cancer Research (149 citations) and Pathology and Forensic Medicine (142 citations). E. A. Eisenhauer has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include J. B. Vermorken, M. van Glabbeke, Elisabeth G.E. de Vries, Geke A.P. Hospers, D.S. Chi, Robert G. Bristow, Karl C. Podratz, Giacomo Aletti, Giovanni Aletti and W CLIBY. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer, International Journal of Gynecological Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.